About Magellan BioScience Group
Magellan BioScience Group is a company based in Tampa (United States) founded in 1997 was acquired by Meridian Bioscience in March 2016.. Magellan BioScience Group has raised $25 thousand across 2 funding rounds from investors including Meridian Bioscience, NIH and Florida High Tech Corridor. Magellan BioScience Group has completed 1 acquisition, including TREK Diagnostic Systems. Magellan BioScience Group offers products and services including Microbial Strains Library and Pure Peptide Library. Magellan BioScience Group operates in a competitive market with competitors including AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others.
- Headquarter Tampa, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Magellan Bioscience Group Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 K (USD)
in 2 rounds
-
Latest Funding Round
$25 K (USD), Unspecified
Sep 17, 2012
-
Investors
Meridian Bioscience
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Meridian Bioscience
(Mar 24, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magellan BioScience Group
Magellan BioScience Group offers a comprehensive portfolio of products and services, including Microbial Strains Library and Pure Peptide Library. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Collection of over 10,000 microbial strains for drug discovery studies.
Over 2400 pure peptides for high-throughput screening assays.
Funding Insights of Magellan BioScience Group
Magellan BioScience Group has successfully raised a total of $25K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $25 thousand completed in September 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Unspecified — $25,000
-
First Round
First Round
(06 Jul 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2012 | Amount | Unspecified - Magellan BioScience Group | Valuation |
investors |
|
| Jul, 2007 | Amount | Grant - Magellan BioScience Group | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Magellan BioScience Group
Magellan BioScience Group has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and Florida High Tech Corridor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
The Florida High Tech Corridor is focused on regional high-tech development.
|
Founded Year | Domain | Location | |
|
Molecular diagnostic device and kits
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Magellan BioScience Group
Magellan BioScience Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TREK Diagnostic Systems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Offers microbiology solution
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Magellan BioScience Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Magellan Bioscience Group Comparisons
Competitors of Magellan BioScience Group
Magellan BioScience Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| domain | founded_year | HQ Location |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| domain | founded_year | HQ Location |
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
|
|
| domain | founded_year | HQ Location |
Research and development services for sugar derivatives are provided.
|
|
| domain | founded_year | HQ Location |
Develops technologies to harness compounds from natural production.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Magellan BioScience Group
When was Magellan BioScience Group founded?
Magellan BioScience Group was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Where is Magellan BioScience Group located?
Magellan BioScience Group is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Is Magellan BioScience Group a funded company?
Magellan BioScience Group is a funded company, having raised a total of $25K across 2 funding rounds to date. The company's 1st funding round was a Grant of $350K, raised on Jul 06, 2007.
What does Magellan BioScience Group do?
Founded in 1997 and based in Tampa, United States, Magellan BioScience Group operates in the biotechnology sector, focusing on microbial natural products. Research libraries with diverse compounds are offered for applications in pharmaceuticals, agrochemicals, specialty chemicals, and animal health care. Services such as microbial biotransformation, synthetic modifications, and structure elucidation are provided, along with separation and spectroscopic analysis. Partnerships have been established with organizations including BioFlorida, AndroBioSys, and Kemin Pharmaceuticals.
Who are the top competitors of Magellan BioScience Group?
Magellan BioScience Group's top competitors include AnalytiCon Discovery, BJ Biochem and Bicoll.
What products or services does Magellan BioScience Group offer?
Magellan BioScience Group offers Microbial Strains Library and Pure Peptide Library.
How many acquisitions has Magellan BioScience Group made?
Magellan BioScience Group has made 1 acquisition, including TREK Diagnostic Systems.
Who are Magellan BioScience Group's investors?
Magellan BioScience Group has 3 investors. Key investors include Meridian Bioscience, NIH, and Florida High Tech Corridor.